Dietary dimethylglycine alleviates cyclic heat stress-induced jejunal injury in yellow-feathered broilers by inhibiting the TLR4/NF-κB signaling pathway and restoring MUC2 expression

Heat stress is a major welfare and productivity problem in poultry farming, and the gut lining is one of the first tissues to suffer. This study tested whether adding dimethylglycine (DMG)—a naturally occurring amino acid derivative involved in methyl-group metabolism—to the diet of yellow-feathered broilers could protect the small intestine (specifically the jejunum) during repeated bouts of high-temperature exposure. The researchers focused on two interconnected problems heat causes in the gut: runaway inflammation driven by the TLR4/NF-κB signaling pathway, and loss of the mucus-producing protein MUC2, which normally coats and shields the intestinal lining. They found that DMG supplementation blunted the inflammatory cascade and restored MUC2 levels, keeping the gut barrier more intact. The results suggest DMG works by interrupting a well-characterized danger-sensing pathway (TLR4 detects stress signals → activates NF-κB → triggers pro-inflammatory cytokine release → damages the mucosa) before it can spiral into tissue injury. Because MUC2 is the backbone of the intestinal mucus layer, its restoration is particularly meaningful: without adequate mucus, bacteria and their products can penetrate the epithelium and amplify inflammation. This work matters beyond poultry science because the TLR4/NF-κB axis and MUC2 are conserved across vertebrates, making findings potentially relevant to heat-related gut injury in other species. Overall, the study positions DMG as a low-cost, feed-additive-compatible strategy to mitigate thermal gut damage.

• Dietary DMG supplementation significantly reduced cyclic heat stress-induced histomorphological damage in the jejunum of yellow-feathered broilers, as evidenced by improved villus integrity and reduced epithelial disruption relative to heat-stressed controls.
• DMG inhibited activation of the TLR4/NF-κB signaling pathway, with downstream reductions in pro-inflammatory cytokine expression (specific cytokines and fold-changes as reported in the study data), indicating an anti-inflammatory mechanism of action.
• MUC2 goblet-cell expression, which was suppressed by cyclic heat stress, was restored toward thermoneutral-control levels in DMG-supplemented birds, suggesting protection of the mucus barrier as a key mechanism underlying the mucosal benefit.

The study used yellow-feathered broilers assigned to treatment groups including a thermoneutral control, a cyclic heat stress group, and one or more DMG-supplemented heat stress groups; cyclic heat stress was applied repeatedly over a defined experimental period to mimic real-world temperature fluctuations. Jejunal tissue was collected and assessed for histomorphology, inflammatory pathway activation (TLR4, NF-κB and associated mediators), and MUC2 expression using techniques such as immunohistochemistry, qPCR, and/or Western blotting. Specific sample sizes per group, DMG dose(s) tested, and the exact heat stress protocol (temperature, duration, number of cycles) are reported in the primary article. Follow-up endpoints were cross-sectional at slaughter rather than longitudinal within individual animals.

Because this is an animal study in a specific poultry breed, direct translation to human gut physiology or other livestock species requires caution—the TLR4/NF-κB mechanism is conserved, but the magnitude of response and effective DMG doses may differ substantially across species. The study examines jejunal tissue at a single end-point, so it cannot capture the kinetics of injury and recovery across the full heat stress cycle, nor determine whether DMG's benefits persist after supplementation is withdrawn. The optimal DMG dose and the relative contribution of its methyl-donor vs. direct anti-inflammatory properties remain unclear and would require dose-response and mechanistic dissection experiments. Future work should also assess gut microbiota composition, barrier permeability (e.g., TEER, tight-junction proteins), and systemic markers of endotoxemia to build a complete picture of DMG's protective scope.

This study extends [§149] (combined heat and exercise stress disrupting gut microbiota and promoting microbial translocation) by identifying a dietary intervention—DMG—that targets the mucosal side of heat-induced gut injury, providing a complementary upstream protective strategy. It parallels [§120], which demonstrates that modulating NF-κB signaling (there via Eubacterium rectale and glutamine metabolism) can mitigate intestinal inflammatory damage, reinforcing NF-κB as a convergent therapeutic target across very different intervention types and disease contexts. The MUC2 restoration finding also connects with [§155] (Saccharomyces boulardii and intestinal barrier function), where a separate agent preserves mucosal integrity through goblet-cell and mucus-layer mechanisms, suggesting that protecting MUC2 expression may be a shared feature of effective gut-barrier interventions regardless of the stressor. Broader corpus context from [§148] (dietary intervention ameliorating gut leakiness in a metabolic stress model) underscores the growing evidence that targeted nutritional strategies can structurally reinforce the intestinal barrier under diverse physiological challenges.

• Combined heat and exercise stress disrupt gut microbiota and promote microbial translocation
  Most direct comparator: both examine heat stress as the primary gut insult, making this the essential mechanistic counterpart—one characterizes the damage (microbiota disruption, translocation), the other tests a dietary fix (DMG-mediated mucosal protection).
• Eubacterium rectale Mitigates Inflammatory Bowel Disease via Modulation of Glutamine Metabolism Through the GLS2 and NF-κB Pathway
  Shares the NF-κB inhibition mechanism but uses a probiotic bacterium (Eubacterium rectale) rather than a small-molecule supplement, allowing readers to compare how different intervention classes converge on the same inflammatory pathway.
• Saccharomyces Boulardii CNCM I-745 on Intestinal Barrier Function
  Both studies address intestinal barrier preservation, but Saccharomyces boulardii operates primarily through tight-junction and microbiota modulation whereas DMG targets TLR4/NF-κB—reading both clarifies which layer of barrier defence each approach most strongly engages.
• Dietary Intervention with Brown Top Millet Starch Ameliorates Dyslipidaemia and Gut Leakiness in High Fat Diet Fed Models
  Offers a parallel dietary-intervention-plus-barrier-leakiness design in a metabolic (high-fat diet) rather than thermal stress model, useful for gauging how broadly nutrient-based gut-protection strategies generalise across stressor types.
• Emapunil attenuates ulcerative colitis by suppressing Z-DNA binding protein 1 driven pyroptosis and pro-inflammatory polarization in macrophages
  Examines NF-κB-linked mucosal inflammation in colitis via a distinct pathway (Z-DNA binding protein 1/pyroptosis), providing mechanistic contrast that highlights which nodes of the NF-κB network are most tractable as intervention targets.